Eye Drops Recall: TRP Eye Twitching Relief Lacks Sterility Assurance
TRP Eye Twitching Relief sterile eye drops are being recalled nationwide because the manufacturer cannot assure the product meets sterility requirements. The affected lot (C303, expiring 07-27-2025) was distributed in the USA.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall for a risk-of-harm medical product (sterile eye drops) where the hazard is theoretical contamination due to lack of sterility assurance, with no reported illnesses or injuries. Per the rubric, such recalls score at most 3 (High).
Plain-English summary
TRP Eye Twitching Relief, a homeopathic sterile eye drop product, is being recalled due to lack of assurance of sterility. The product is a 0.33 FL OZ (10 mL) eye drop manufactured by Optikem International, Inc. for TRP Company, Inc.
The recall was initiated because the manufacturer cannot assure that the product meets sterility requirements. Sterile eye drops must be free from contamination to prevent eye infections and other serious ocular complications.
The recall affects 9,936 bottles distributed nationwide in the USA. The affected lot is #C303 with an expiration date of 07-27-2025. The product's NDC number is 17312-040-15.
Consumers who have purchased this product should stop using it and contact their healthcare provider if they have used it. Consumers should consult the FDA website or their pharmacist for proper disposal instructions.
The recalled product
- Product
- TRP Eye Twitching Relief, Sterile Eye Drops, Homeopathic 0.33 FL OZ (10 mL), Manufactured for TRP Company, Inc, 1575 Delucchi Lane, Suite # 208, Reno, NV, NDC # 17312-040-15.
- Manufacturer
- Optikem International, Inc.
- Category
- Drug — Eye Drops
- Hazard
- lack-of-sterility
- contamination-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: C303
- Exp: 07-27-2025
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27